A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Tadalafil Impurity 71 | Tadalafil Impurity 71. Uses: For analytical and research use. Molecular formula: C22H19N3O6. Mole weight: 421.21. Catalog: APB09853. |  |
| Tadalafil Impurity 72 | Tadalafil Impurity 72. Uses: For analytical and research use. CAS No. 1978323-00-0. Molecular formula: C22H17N3O5. Mole weight: 403.39. Catalog: APB1978323000. | |
| Tadalafil Impurity 73 | Tadalafil Impurity 73. Uses: For analytical and research use. Molecular formula: C19H14N4O6. Mole weight: 394.34. Catalog: APB09855. | |
| Tadalafil Impurity 74 | Tadalafil Impurity 74. Uses: For analytical and research use. Molecular formula: C22H18N4O5. Mole weight: 418.41. Catalog: APB09857. | |
| Tadalafil Impurity 75 | Tadalafil Impurity 75. Uses: For analytical and research use. Molecular formula: C19H15N3O5. Mole weight: 365.35. Catalog: APB09854. | |
| Tadalafil Impurity 76 | Tadalafil Impurity 76. Uses: For analytical and research use. Molecular formula: C19H15N3O5. Mole weight: 365.35. Catalog: APB09856. | |
| Tadalafil Impurity 77 | Tadalafil Impurity 77. Uses: For analytical and research use. CAS No. 1220393-12-3. Molecular formula: C22H19N3O5. Mole weight: 405.41. Catalog: APB1220393123. | |
| Tadalafil Impurity 78 | Tadalafil Impurity 78. Uses: For analytical and research use. Molecular formula: C24H20Cl2N2O6. Mole weight: 503.33. Catalog: APB09858. | |
| Tadalafil Impurity 79 | Tadalafil Impurity 79. Uses: For analytical and research use. Molecular formula: C45H41N5O10. Mole weight: 811.85. Catalog: APB09859. | |
| Tadalafil Impurity 80 | Tadalafil Impurity 80. Uses: For analytical and research use. Molecular formula: C22H21N3O4. Mole weight: 391.43. Catalog: APB09860. | |
| Tadalafil Impurity 81 | Tadalafil Impurity 81. Uses: For analytical and research use. Molecular formula: C23H20N2O5. Mole weight: 404.42. Catalog: APB09861. | |
| Tadalafil Impurity 82 | Tadalafil Impurity 82. Uses: For analytical and research use. Molecular formula: C38H28N4O6. Mole weight: 636.66. Catalog: APB09862. | |
| Tadalafil Impurity 83 | Tadalafil Impurity 83. Uses: For analytical and research use. CAS No. 2237219-65-5. Molecular formula: C24H23N3O5. Mole weight: 433.46. Catalog: APB2237219655. | |
| Tadalafil Impurity B | One of the impurities of Tadalafil, which is an inhibitor of phosphodiesterase 5 and could be used in the treatment of erectile dysfunction. Alternative Names: (6R,12aS)-6-(1,3-benzodioxal-5yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]-1,4-dione. Grades: > 95%. CAS No. 951661-82-8. Molecular formula: C20H19N3O3. Mole weight: 349.39. |  |
| Tadalafil Impurity D | One of the impurities of Tadalafil, which is an inhibitor of phosphodiesterase 5 and could be used in the treatment of erectile dysfunction. Alternative Names: (6bR)-12-(1,3-Benzodioxol-5-yl)-12a-hydroxy-8-methyl-6a,6b,8,9,12,12a-hexahydropyrazino[1,2:1,2]-pyrrolo[3,4-c]quinoline-6,7,10(5H)-trione. Grades: > 95%. CAS No. 951661-81-7. Molecular formula: C22H20ClN3O4. Mole weight: 425.88. | |
| Tadalafil Impurity N98 | Tadalafil Impurity N98. CAS No. 1795790-92-9. | |
| Tadalafil-methyl-d3 | Used for the treatment of erectile dysfunction. A phosphodiesterase 5 inhibitor. Group: Biochemicals. Alternative Names: Cialis-methyl-d3. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. |  Worldwide |
| Tadalafil Spiro-oxindole | Tadalafil Spiro-oxindole. Group: Biochemicals. Alternative Names: Tadalafil Impurity. Grades: Highly Purified. Pack Sizes: 2.5mg. Molecular Formula: C22H19N3O5, Molecular Weight: 405.4. US Biological Life Sciences. | Worldwide |
| Tadalafil (Standard) | Tadalafil (Standard) is the analytical standard of Tadalafil. This product is intended for research and analytical applications. Tadalafil (IC-351) is a PDE5 inhibitor with an IC50 value of 1.8 nM. Uses: Scientific research. Category: Signaling pathways. Alternative Names: IC-351 (Standard). CAS No. 171596-29-5. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-90009AR. |  |
| TA DNA Polymerase | TA DNA Polymerase. Ta dna polymerase is a mixture of taq dna polymerase with a proofreading 3-5 exonuclease. the fidelity is equal to hifi pfu dna polymerase. the yield is equal to that from taq dna polymerase. it is more suitable for high fidelity ta cloning. ta dna polymerase offers 18-fold fidelity as compared to taq dna polymerase. extension rate is about 1-2 kb/min. template-independentacan be generated at the 3end of the pcr product. amplification of genomic dna fragment up to 8 kb. Group: Cloning Enzymes. Purity: 250U; 500U. Storage: Store at -20 ?. Cat No: CE-3024. |  |
| Tadnersen | Tadnersen (BIIB078), an antisense oligonucleotide (ASO), selectively targets C9ORF72 transcript variants 1 and 3 that carry the expansion. Alternative Names: BIIB078; BIIB 078; BIIB-078; IONIS-C9Rx. CAS No. 2170507-65-8. | |
| Tadnersen | Tadnersen (BIIB078), an antisense oligonucleotide (ASO), selectively targets C9ORF72 transcript variants 1 and 3 that carry the expansion[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BIIB078; IONIS-C9Rx. CAS No. 2170507-65-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-132581. | |
| Tadocizumab | Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: C4G1; YM-337. CAS No. 339086-80-5. Pack Sizes: 1 mg; 5 mg. Product ID: HY-P99560. | |
| TAE648 | TAE648 is a PROTAC target protein ligand (Ligand for Target Protein for PROTAC). TAE648 can be used for synthesis PROTAC SK-3-91 (HY-137341)[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2769753-10-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-169396. | |
| TAE buffer (50X) | 1lt Pack Size. Group: Biochemicals, Buffers. Formula: N/A. Prepack ID 12439469-1lt. See USA prepack pricing. |  |
| Tafamidis | Tafamidis is a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. It is a drug for the amelioration of transthyretin-related hereditary amyloidosis. It functions by kinetic stabilization of the correctly folded tetrameric form of the transthyretin (TTR) protein and binds selectively and with negative cooperativity to the two normally unoccupied thyroxine-binding sites of the tetramer, and kinetically stabilizes TTR. Alternative Names: Fx-1006A; Vyndaqel. Grades: >98%. CAS No. 594839-88-0. Molecular formula: C14H7Cl2NO3. Mole weight: 308.12. | |
| Tafamidis | Tafamidis is a potent and selective transthyretin (TTR) stabilizer, shows comparable potency and efficacy to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR, with EC50s of 2.7-3.2 μM. Tafamidis inhibits amyloidogenesis[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 594839-88-0. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-14852. | |
| Tafamidis | Used (as its meglumine salt) for the amelioration of transthyretin-related hereditary amyloidosis. It has a role as a central nervous system drug. Category: Other apis. Synonyms: Vyndamax. FX-1006. 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid. CAS No. 594839-88-0. Product ID: API594839880. Molecular formula: C14H7Cl2NO3. Mole weight: 308.1. SMILES: C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl. |  |
| Tafamidis acyl-β-D-glucuronide | Tafamidis acyl-β-D-glucuronide is a metabolite of Tafamidis, a drug used to treat transthyretin amyloidosis. Alternative Names: 1-[2-(3,5-Dichlorophenyl)-6-benzoxazolecarboxylate] β-D-glucopyranuronic acid; Tafamidis acyl glucuronide; (2S,3S,4S,5R,6S)-6-[2-(3,5-Dichlorophenyl)-1,3-benzoxazol-6-ylcarbonyloxy]-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid; 6-Carboxy-2-(3,5-dichlorophenyl)-benzoxazole β-D-glucopyranuronic acid; Fx 1006 β-D-glucopyranuronic acid; Vyndamax β-D-glucopyranuronic acid. Grades: ≥95%. Molecular formula: C20H15Cl2NO9. Mole weight: 484.24. | |
| Tafamidis-[d3] | Tafamidis-[d3] is deuterium labelled Tafamidis. Tafamidis is a potent and selective transthyretin (TTR) stabilizer, showing comparable potency and efficacy to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR, with EC50s of 2.7-3.2 μM. Tafamidis inhibits amyloidogenesis. Alternative Names: Tafamidis-d3; d3-Tafamidis. Molecular formula: C14H4D3Cl2NO3. Mole weight: 311.13. | |
| Tafamidis meglumine | Tafamidis meglumine (Fx-1006A) is a potent and selective transthyretin (TTR) stabilizer, shows comparable potency and efficacy to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR, with EC50s of 2.7-3.2 μM. Tafamidis meglumine inhibits amyloidogenesis[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Fx-1006A. CAS No. 951395-08-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-14852A. | |
| Tafamidis (Standard) | Tafamidis (Standard) is the analytical standard of Tafamidis. This product is intended for research and analytical applications. Tafamidis is a potent and selective transthyretin (TTR) stabilizer, shows comparable potency and efficacy to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR, with EC50s of 2.7-3.2 μM. Tafamidis inhibits amyloidogenesis[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 594839-88-0. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-14852R. | |
| Tafasitamab | Tafasitamab (XmAb5574) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigenCD19[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: XmAb5574; MOR00208; Tafasitamab-cxix; MOR-208. CAS No. 1422527-84-1. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-P9981. | |
| Tafenoquine | Tafenoquine (WR 238605) is an 8-aminoquinoline. Tafenoquine is an anti-malarial prophylactic agent[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: WR 238605. CAS No. 106635-80-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-111529. | |
| Tafenoquine | Tafenoquine is an oral active and an 8-aminoquinoline antimalaria drug. It is being investigated as a potential treatment for malaria, as well as for malaria prevention.It is for treatment of the hypnozoite stages of Plasmodium vivax and Plasmodium ovale that are responsible for relapse of these malaria species even when the blood stages are successfully cleared. It targets leishmania respiratory complex III and induces apoptosis. It has a long half-life of approximately 14 days and is generally safe and well tolerated, thus therefore a single treatment may be sufficient to clear hypnozoites. It was manufactured by GlaxoSmithKline and in clinic phase 3 trials. Uses: Tafenoquine is being investigated as a potential treatment for malaria, as well as for malaria prevention.it is for treatment of the hypnozoite stages of plasmodium vivax and plasmodium ovale. Alternative Names: 4-[5-[3-(Trifluoromethyl)phenoxy]-2,6-dimethoxy-4-methyl-8-quinolinylamino]-1-pentanamine;8-[(4-Amino-1-methylbutyl)amino]-2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinoline;N4-(2,6-diMethoxy-4-Methyl-5-(3-(trifluoroMethyl)phenoxy)quinolin-8-yl)pentane-1,4-diamine;WR-238605;WR238605;Etaquine. Grades: >98%. CAS No. 106635-80-7. Molecular formula: C24H28F3N3O3. Mole weight: 463.50. | |
| Tafenoquine | Tafenoquine is an 8-aminoquinoline,and is an agent of anti-malarial prophylactic. Category: Active pharmaceutical ingredients. Synonyms: WR 238605. CAS No. 106635-80-7. Product ID: API106635807. Molecular formula: C24H28F3N3O3. Mole weight: 463.49. | |
| Tafenoquine Succinate | Tafenoquine Succinate (WR 238605 Succinate) is an 8-aminoquinoline. Tafenoquine is an anti-malarial prophylactic agent[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: WR 238605 Succinate. CAS No. 106635-81-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-111529A. | |
| Tafenoquine Succinate | Tafenoquine Succinate (WR 238605 (Succinate)) is an 8-aminoquinoline. and is an agent of anti-malarial prophylactic. Category: Active pharmaceutical ingredients. CAS No. 106635-81-8. Product ID: API106635818. Molecular formula: C28H34F3N3O7. Mole weight: 581.58. | |
| Tafenoquine Succinate | Tafenoquine is a medication for the prevention and treatment of malaria. Alternative Names: WR 238605; WR-238605; WR238605. CAS No. 106635-81-8. Molecular formula: C28H34F3N3O7. Mole weight: 581.6. | |
| Tafluprost | Tafluprost is a novel prostanoid analogue that activates Prostaglandin Receptor. It is used in the treatment of glaucoma and is the first prostanoid to be released in a preservative free-formula. Alternative Names: AFP-168, AFP-168, AFP-168, MK-2452, MK2452, MK 2452, Taflotan; Zioptan; AFP-168; Saflutan; propan-2-yl (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate. Grades: ≥ 98%. CAS No. 209860-87-7. Molecular formula: C25H34F2O5. Mole weight: 452.539. | |
| Tafluprost | Tafluprost (AFP-168) is an anti-glaucoma prostaglandin (PG) analog. Tafluprost can inhibit the apoptosis of retinal ganglion cells (RGCs) and rat RGCs cells. Tafluprost promotes axon regeneration by regulating Zn2+-mTORpathway, inhibits intracellular lipid accumulation in human preorbital adipocytes. Tafluprost can be used in the study of optic nerve injury in glaucoma[1][2][3][4][5]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AFP-168; MK2452. CAS No. 209860-87-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-B0600. | |
| Tafluprost | Tafluprost, a prostaglandin analog, is the selective agonist of fluoroprostaglandin (FP) receptor PGF2α. Category: Active pharmaceutical ingredients. CAS No. 209860-87-7. Product ID: API209860877. Molecular formula: C25H34F2O5. Mole weight: 452.53. | |
| Tafluprost | Tafluprost. Group: Biochemicals. Alternative Names: (5Z)-7-[(1R,2R,3R,5S)-2-[(1E)-3,3-Difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic Acid 1-Methylmethyl Ester; AFP 168; MK 2452; Taflotan; Tapros. Grades: Highly Purified. CAS No. 209860-87-7. Pack Sizes: 2.5mg. Molecular Formula: C25H34F2O5, Molecular Weight: 452.53. US Biological Life Sciences. | Worldwide |
| Tafluprost acid | Tafluprost acid is a pharmaceutical compound used as an indispensable constituent within ophthalmic tools. This compound is renowned for its remarkable capacity in studying intraocular pressure. Alternative Names: (Z)-7-[(1R,2R,3R,5S)-2-((E)-3,3-Difluoro-4-phenoxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl]hept-5-enoic Acid; 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-Difluoro-4-phenoxy-1-butenyl]-3,5-dihydroxycyclopentyl]-5-Heptenoic Acid; AFP 172. Grades: > 95%. CAS No. 209860-88-8. Molecular formula: C22H28F2O5. Mole weight: 410.46. | |
| Tafluprost acid | Tafluprost acid (AFP-172), an active metabolic form of Tafluprost, is a selective prostanoid FP receptor agonist. Tafluprost acid shows a high affinity for human prostanoid FP receptor with Ki and EC50 values of 0.4 nM and 0.53 nM, respectively. Tafluprost acid has 126 times weaker binding affinity for prostanoid EP3 receptor (IC50=67 nM) than for the prostanoid FP receptor. Tafluprost acid can be used in the research of glaucoma[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AFP-172. CAS No. 209860-88-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-B0601. | |
| Tafluprost-d7 | Tafluprost-d7. Group: Biochemicals. Alternative Names: (5Z)-7-[(1R,2R,3R,5S)-2-[(1E)-3,3-Difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic Acid 1-Methylmethyl Ester-d7; AFP 168-d7; MK 2452-d7; Taflotan-d7; Tapros-d7. Grades: Highly Purified. Pack Sizes: 1mg. Molecular Formula: C25H27D7F2O5, Molecular Weight: 459.57. US Biological Life Sciences. | Worldwide |
| Tafluprost ethyl amide | Tafluprost ethyl amide is a highly potent and significant compound utilized in studying the prevalent ocular maladies of glaucoma and ocular hypertension employing a mechanism of action that selectively engages and enhances the outflow of the aqueous humor via specific receptors in the eye. Alternative Names: Taflpostamide; (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]-N-ethylhept-5-enamide. CAS No. 1185851-52-8. Molecular formula: C24H33F2NO4. Mole weight: 437.5. | |
| Tafluprost ethyl ester | Tafluprost ethyl ester is an analog of prostaglandin F2α (PGF2α), which has been approved for the treatment of glaucoma. Alternative Names: AFP 175; Ethyl (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate. Grades: ≥98%. CAS No. 209860-89-9. Molecular formula: C24H32F2O5. Mole weight: 438.5. | |
| Tafluprost Impurity 10 | Tafluprost Impurity 10. Uses: For analytical and research use. CAS No. 40665-68-7. Molecular formula: C11H15O5P. Mole weight: 258.21. Catalog: APB40665687. | |
| Tafluprost Impurity 11 | Tafluprost Impurity 11. Uses: For analytical and research use. CAS No. 39746-00-4. Molecular formula: C15H16O5. Mole weight: 276.29. Catalog: APB39746004. | |
| Tafluprost Impurity 12 | Tafluprost Impurity 12. Uses: For analytical and research use. Molecular formula: C25H33F3O5. Mole weight: 470.53. Catalog: APB09865. | |
| Tafluprost Impurity 13 | Tafluprost Impurity 13. Uses: For analytical and research use. Molecular formula: C25H33FO5. Mole weight: 432.53. Catalog: APB09866. | |
| Tafluprost Impurity 15 | Tafluprost Impurity 15. Uses: For analytical and research use. Molecular formula: C25H33FO5. Mole weight: 432.53. Catalog: APB09868. | |
| Tafluprost Impurity 19 | Tafluprost Impurity 19. Uses: For analytical and research use. CAS No. 2587078-46-2. Molecular formula: C25H35FO5. Mole weight: 434.55. Catalog: APB2587078462. | |
| Tafluprost Impurity 20 | Tafluprost Impurity 20. Uses: For analytical and research use. Molecular formula: C25H34F2O6. Mole weight: 468.54. Catalog: APB09867. | |
| Tafluprost Impurity 21 | Tafluprost Impurity 21. Uses: For analytical and research use. Molecular formula: C24H32F2O5. Mole weight: 438.51. Catalog: APB09869. | |
| Tafluprost Impurity 22 | Tafluprost Impurity 22. Uses: For analytical and research use. CAS No. 2587078-47-3. Molecular formula: C25H34F2O5. Mole weight: 452.54. Catalog: APB2587078473. | |
| Tafluprost Impurity 7 | Tafluprost Impurity 7. Uses: For analytical and research use. CAS No. 733036-94-7. Molecular formula: C25H35FO5. Mole weight: 434.55. Catalog: APB733036947. | |
| Tafluprost Impurity 8 | Tafluprost Impurity 8. Uses: For analytical and research use. CAS No. 2278245-92-2. Molecular formula: C27H41BrO5. Mole weight: 525.52. Catalog: APB2278245922. | |
| Tafluprost Impurity 8 | Tafluprost Impurity 8. Uses: For analytical and research use. Alternative Names: (3aR,4S,5S,6aS)-4-(hydroxymethyl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate. Molecular formula: C15H16O5. Mole weight: 276.28. Catalog: APB01978. | |
| Tafluprost Impurity 9 | Tafluprost Impurity 9. Uses: For analytical and research use. Alternative Names: (3aR,4R,5R,6aS)-4-(hydroxymethyl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate. Molecular formula: C15H16O5. Mole weight: 276.28. Catalog: APB01975. | |
| Tafluprost Impurity 9 | Tafluprost Impurity 9. Uses: For analytical and research use. CAS No. 2099033-66-4. Molecular formula: C27H41NO8. Mole weight: 507.62. Catalog: APB2099033664. | |
| Tafluprost Impurity DCP-1 | Tafluprost Impurity DCP-1. Uses: For analytical and research use. CAS No. 209860-88-8. Molecular formula: C22H28F2O5. Mole weight: 410.46. Catalog: APB209860888. | |
| Tafluprost Impurity DCP-2 | Tafluprost Impurity DCP-2. Uses: For analytical and research use. CAS No. 1563176-58-8. Molecular formula: C25H34F2O5. Mole weight: 452.54. Catalog: APB1563176588. | |
| TAG-1 A2 (78-86) | TAG-1 A2 (78-86). | |
| TAG-2 (42-50) | TAG-2 (42-50). | |
| Tagarafdeg | Tagarafdeg (CFT1946) is an orally active, CRBN-based and mutant-selective bifunctional degradation activating compound (BiDAC) degrader of BRAFV600E with a DC50 of 14 nM in A375 cells. Tagarafdeg is capable of degrading BRAF V600E (Class I), G469A (Class II), G466V (Class III) mutations, and the p61-BRAFV600E splice variant. Tagarafdeg can be used in tumor research[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: CFT1946. CAS No. 2882165-79-7. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg. Product ID: HY-153341. | |
| Tagat O | Tagat O. Alternative Names: PEG-20 Glyceryl Oleate; Polyoxyethylene glycerin monooleate; Polyoxyethylene glycerol monoleate; TMGO 20; Polyoxyethylene glyceryl monooleate; TMGO; Polyethylene glycol glyerol ether monooleate; Poly(oxyethylene glycerol monooleate). CAS No. 51192-09-7. | |
| Tagatose | Tagatose is a white, anhydrous crystalline solid. It is a carbohydrate, a ketohexose, an epimer of D-fructose inverted at C-4. It can exist in several tautomeric forms. Synonyms: D-lyxo-Hexulose; (3S, 4S, 5R)-2-(hydroxymethyl)oxane-2, 3, 4, 5- tetrol; Naturlose; D-tagatose; tagatosum; tagatoza. CAS No. 87-81-0. Product ID: PE-0495. Molecular formula: C6H12O6. Mole weight: 180.16. Category: Sweetening agent. Product Keywords: Pharmaceutical Excipients; Excipients for Solid Dosage Form; Tagatose; Sweeteners Excipients; Sweetening agent; C6H12O6; 87-81-0; 87-81-0. UNII: T7A20Y888Y. Chemical Name: (3S, 4S, 5R)-1, 3, 4, 5, 6-pentahydroxyhexan-2-one. Administration route: oral and rectal. Dosage Form: oral and rectal solutions. Stability and Storage Conditions: Tagatose is stable under pH conditions typically encountered in foods (pH > 3). It is a reducing sugar and undergoes the Maillard reaction. Tagatose is stable under typical storage conditions. It caramelizes at elevated temperature. Source and Preparation: Tagatose is obtained from D-galactose by isomerization under alkaline conditions in the presence of calcium. Applications: Tagatose is used as a sweetening agent in beverages, foods, and pharmaceutical applications. A 10% solution of tagatose is about 92% as sweet as a 10% sucrose solution.It is a low-calorie sugar with approximately 38% of the calories of sucrose per gram. It occurs naturally in low levels in milk pro |  |
| Tagatose | Tagatose is used as a sweetener in beverages, foods and pharmaceutical applications. It is also used as a bulk sweetener, humectant, texturizer, and stabilizer, and may be used in dietetic foods with a low glycemic index. Alternative Names: D-Tagatose; D-lyxo-Hexulose; (3S,4S,5R)-2-(hydroxymethyl)oxane-2,3,4,5-tetrol; Naturlose; tagatosum; tagatoza; lyxo-2-Hexulose; D(-)-Tagatose. Grades: ≥98%. CAS No. 87-81-0. Molecular formula: C6H12O6. Mole weight: 180.16. | |
Our database is helping our users find suppliers everyday.
